In a normal administration, Mike Flynn would be kept at arm’s length. In the Trump administration, he’s been rewarded with a new appointment.

U.S. President Donald Trump on Monday named Michael Flynn, his former national security adviser who challenged the 2020 ...

Indiana basketball beat Ohio State on Saturday in Mike Woodson's final game at Simon Skjodt Assembly Hall. After the win, IU honored Woodson with a video. "Coach Bob Knight, he took a chance on a ...

Nvidia (NASDAQ:NVDA) is gearing up for its annual GTC conference next week, and analysts at Wedbush Securities think it could be a major moment for the tech sector. With concerns over tariffs ...

Mike Verdu, who was tapped as Netflix‘s first head of its young video game division in 2021, has exited the streamer. Verdu left Netflix in February, Variety has confirmed, a move that came ...

AUGUSTA, Maine (WABI) - A popular Maine radio personality has passed away. WTOS posted Wednesday that Mike Estrada, known as Mr. Mike on the Mountain Morning Show, died Tuesday night. Mr. Mike ...

Big Brother alum Mike “Boogie” Malin has been arrested again. It comes less than a week after a story broke that Malin had been arrested fpor allegedly shoplifting at a CVS pharmacy.

Wedbush became the latest brokerage to downgrade Arvinas (NASDAQ:ARVN) on Wednesday after the company posted underwhelming late-stage trial data for vepdegestrant, an experimental breast cancer ...

Nvidia (NASDAQ:NVDA) is gearing up for its annual GTC conference next week, and analysts at Wedbush Securities think it could be a major moment for the tech sector. With concerns over tariffs, ...

Wedbush analyst Laura Chico maintained a Buy rating on Astria Therapeutics (ATXS – Research Report) today and set a price target of $28.00. The company’s shares closed yesterday at $6.47 ...

Wedbush lowered the firm’s price target on RumbleON (RMBL) to $5 from $5.50 and keeps an Outperform rating on the shares. The firm notes the company reported Q4 results that came in a bit below ...

Wedbush downgraded Arvinas (ARVN) to Neutral from Outperform with a price target of $12, down from $57. Effectively assess a stock's risks and opportunities with a clear breakdown of its positive ...